Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Covis Pharmaceuticals
Covis Pharmaceuticals
Activities:
Manufacturing
Cardiovascular
Mental Health
Pharmaceutical
Cognitive
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Covis Pharma names Chairman of the Board
Rajiv De Silva has been chosen as Chairman of the Board of Director effective immediately
Covis Pharma appoints Dean Mitchell as Executive Chairman
Takes responsibility for leadership of Covis Pharma Holdings and for the overall direction of the company
Finance
Covis Pharma gains rights to certain GSK drugs in US and Puerto Rico
Covis aims to build sales in new and adjacent therapeutic areas
Subscribe now